Shi, X. et al. 2026. Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin. Gastroenterology Research. 19, 5 (Jan. 2026), 295–301. DOI:https://doi.org/10.14740/gr2193.